课题基金 / 基金详情

Molecular and Pathological Analysis of Anticoagulant Heparan Sulfate Proteoglycan from Endothelial Cell

Molecular and Pathological Analysis of Anticoagulant Heparan Sulfate Proteoglycan from Endothelial Cell
内皮细胞抗凝硫酸乙酰肝素蛋白多糖的分子和病​​理学分析
批准号:
05454330
负责人:
SAITO Hidehiko
金额:
$4.86万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1994

项目摘要

项目成果

SAITO Hidehiko的其他基金

相似基金

相关文献

中文摘要
翻译
我们已经分离到一个编码2,610个核苷酸转录本的人ryudocan核心蛋白的cDNA,该转录本编码一个198个氨基酸的蛋白质。人和大鼠Ryudocan的核心蛋白的比较表明,它们具有高度的结构保守性,特别是在推测的成熟核心蛋白的NH2和COOH末端区域,这可能在Ryudocan的生物学功能中发挥重要作用。在所有被测试的组织中都检测到一个2.7kb的主要转录本,在肺、肝、骨骼肌和肾脏的mRNA中观察到相对高水平的表达。在一些组织中也观察到了一条1.9kb的小转录本,这可能是由交替的多聚腺苷作用引起的。人ryudocan基因经荧光原位杂交定位于染色体20q12。用抗人ryudocan核心蛋白的多克隆抗体进行免疫组织化学分析,发现ryudocan在胎盘绒毛滋养层细胞和新生血管内皮细胞中均有表达,而在正常血管中不表达。人Ryudocan核心蛋白基因的分离为我们研究Ryudocan的表达调控及该分子在人内皮细胞功能中的作用奠定了基础
英文摘要
We have isolated a cDNA of the human ryudocan core protein encoding a 2,610 bp transcript, which potentially codes for a 198 amino acid protein. Comparison of the deduced core proteina between the human and the rat ryudocan revealed that they have high structural conservation, particularly in the NH_2 and COOH terminus regions of the putative mature core protein, which might serve important roles for biological function of ryudocan. A major 2.7kb transcript was detected in all tissues tested, with relatively high levels of expression observed in mRNA from lung, liver, skeletal muscle and kidney. A minor 1.9 kbtranscript was also observed in some of tissues, which would be caused by alternative polyadenylation. Human ryudocan gene has localized on the chromosome 20q12 by fluorescence in situ hybridization. Immuno-histochemical analysis using a specific polyclonal antibody against human ryudocan core protein revealed that ryudocan was expressed in trophoblasts of placental villi and in endothlial cells of neovesseles, but not in those of normal vesseles. Isolation of the human ryudocan core protein cDNA will allow us to study for the regulation of ryudocan expression and the role of this molecule in human endothelial cell function
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yamamoto,K.: "Homozygous protein C deficiency:indentification of a novel missense mutation that causes impaired secretion of the mutant protein C." J Lab Clin Med. 119. 87-95 (1992)
Yamamoto,K.:“纯合蛋白 C 缺陷:鉴定出一种新的错义突变,该突变会导致突变蛋白 C 的分泌受损。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sugiura,I.: "Three distinct point mutations of the von Willebrand factor gene in four patients with type IIA von Willebrand disease." Thromb Haemost. 67. 612-617 (1992)
Sugiura,I.:“四名 IIA 型冯维勒布兰德病患者的冯维勒布兰德因子基因出现三种不同的点突变。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hidehiko Saito et al.: "Human Ryudocan Core Protein:Molecular Cloning and Chavacteriqation of the cDNA,and Chromosomal Localiqation of the Gene." Biochem.Biophys.Res.Commun.190. 814-822 (1993)
Hidehiko Saito 等人:“人类 Ryudocan 核心蛋白:cDNA 的分子克隆和 Chavacteriqation,以及基因的染色体定位。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 9 条
    Elucidation of molecular basis of May-Hegglin anomaly and its related disordes
    Down-regulation of murine tissue factor pathway inhibitor mRNA by endotoxin and tumor neerosis factor-alpha In vitro and In vivo.
    • 批准号:
      11470209
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $9.41万
    • 财政年份:
      1999
    • 负责人:
      SAITO Hidehiko
    • 依托单位:
    Novel immunotherapy for Hematological Malignancy
    • 批准号:
      11557074
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $8.38万
    • 财政年份:
      1999
    • 负责人:
      SAITO Hidehiko
    • 依托单位:
    Molecular Biological Analysis for Mechanism of Thombosis Regulation and Its Aplication for Clinical Desease.
    • 批准号:
      09470228
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.94万
    • 财政年份:
      1997
    • 负责人:
      SAITO Hidehiko
    • 依托单位:
    海外基金